Immune checkpoints (ICPs) (e.g., PD1 and PDL1) and immunogenic cell death modulators (e.g., HGF and IFN) are crucial for modulating the immune responses of effectors and maintaining the self-tolerance of tumor to minimize tissue damage (45, 46). This evidence concerns the gene HGF and neoplasm.